Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Januar 2025

NOVO — Januar 2025

Planlagt Fastgjort Låst Flyttet NOVO
233 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #178

    Novo imponerer med vægttabsdata: "Det her kan vende stemningen i aktien" https://proinvestor.com/investornyt/1269021/novo-imponerer-med-vaegttabsdata-det-her-kan-vende-stemningen-i-aktien

    1 Reply Last reply
    0
    • U Offline
      U Offline
      UlrikChristiansen8
      wrote on sidst redigeret af
      #179

      hvad var konsensus får disse data?

      1 Reply Last reply
      0
      • U Offline
        U Offline
        UlrikChristiansen8
        wrote on sidst redigeret af
        #180

        for*

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #181

          Fed nyhed, så starter de vel nok snart produktion i Kalundborg. Måske inden for kommende 12 mdr

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #182

            fase 1/2 data

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #183

              Sydbank om Novo: Fuldstændig fair kursreaktion på stærke vægttabsdata https://proinvestor.com/investornyt/1269139/sydbank-om-novo-fuldstaendig-fair-kursreaktion-pa-staerke-vaegttabsdata

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #184

                Novos markedsværdi steg 183 mia. kr. efter stærke fedmedata https://proinvestor.com/investornyt/1269198/novos-markedsvaerdi-steg-183-mia-kr-efter-staerke-fedmedata

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  koden
                  wrote on sidst redigeret af
                  #185

                  endte "kun" 7% oppe

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #186

                    jeg hæfter mig ved "vendingen" og 7% er ikke dårligt

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #187

                      detalje, der "blot gør dagens nye resultater endnu mere imponerende." https://www.shareholders.dk/nyhed/novo-aktien-i-markant-stigning-efter-nye-data?utm_source=Aktionærens Nyhedsbrev&utm_campaign=be4509cbe1-20-07-2024_COPY_01&utm_medium=email&utm_term=0_bfc53fad21-be4509cbe1-90602917

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #188

                        Godmorgen 🙂

                        1 Reply Last reply
                        0
                        • R Offline
                          R Offline
                          Riis7
                          wrote on sidst redigeret af
                          #189

                          godmorgen:_)

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Riis7
                            wrote on sidst redigeret af
                            #190

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              JKY_VH
                              wrote on sidst redigeret af
                              #191

                              Tak Riis7

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #192

                                Novo Nordisk’s Amycretin: A Glimpse into the Future of GLP-1 Weight Loss Treatments https://www.onthepen.com/post/novo-nordisk-s-amycretin-a-glimpse-into-the-future-of-glp-1-weight-loss-treatments?utm_campaign=e6280513-1189-4af4-8ad5-bb1922b1e58a&utm_source=so&utm_medium=mail&cid=713e80cd-1fa6-468e-90d7-68fd62c5df0e

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  koden
                                  wrote on sidst redigeret af
                                  #193

                                  Vi skal lige huske at studiet på Amycretin er et fase 1b/2a studie. Muligt de får lov at springe til fase 3. Men Cagrisema er vel stort set produktionsklar?

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Svend_Skriver
                                    wrote on sidst redigeret af
                                    #194

                                    'Virker usandsynligt, at Novo Nordisk rammes af potentiel toldsats, siger analytiker' Søren Løntofts vurdering. NB: Indslaget fra 22/1 2025.
                                    https://nyheder.tv2.dk/live/udland/2025-01-18-trump-i-det-hvide-hus?entry=87246090-06e0-4e85-b939-4c550c316c73

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      koden
                                      wrote on sidst redigeret af
                                      #195

                                      nej medmindre at trump vil presse DK om Grønland. Men de har jo brug for wegovy, så næppe.

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #196

                                        Fra Reuters "Veru said on Monday its
                                        experimental drug, in combination with Novo Nordisk's
                                        weight-loss treatment Wegovy, helped preserve muscle in older
                                        patients with obesity, meeting the main goal of a mid-stage
                                        study.
                                        The study was testing Veru's oral drug, enobosarm, in
                                        patients aged 60 and above. The drug targets androgen hormones,
                                        which play a role in body development and reproductive health.
                                        Patients who received the drug in combination with
                                        Wegovy lost 71% less lean muscle on average than

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #197

                                          those who
                                          received Wegovy alone, the company said."

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper